• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

霉酚酸酯致肾移植受者粒细胞缺乏症。

Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient.

机构信息

Department of Nephrology and Hypertension, Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Miyamae-Ku, Kawasaki, Kanagawa 216-8511, Japan.

出版信息

Clin Exp Nephrol. 2010 Dec;14(6):637-40. doi: 10.1007/s10157-010-0323-y. Epub 2010 Aug 7.

DOI:10.1007/s10157-010-0323-y
PMID:20694498
Abstract

A 27-year-old woman underwent living kidney transplantation from her mother. She received basiliximab, tacrolimus, mycophenolate mofetil (MMF), and a corticosteroid. Before transplantation, her complete blood count and white cell differential were normal. On about the 70th postoperative day (POD 70), her white blood cell (WBC) count began to decrease. On POD 113, her WBC count was 2800/μL. There was no evidence of viral infection, other systemic infection or malignancy. Drug-induced neutropenia, especially MMF-induced neutropenia, was suspected, and the dosage of MMF was reduced. However, the neutrophil count fell to 0/μL within 2 weeks. We further reduced the dosage of MMF and administered granulocyte-colony stimulating factor (G-CSF), which only temporarily increased the neutrophil count. Then, MMF was discontinued and switched to azathioprine, resulting in recovery of neutrophil count without subsequent rejection. MMF-induced neutropenia frequently occurs and should be monitored not only by WBC count but also by white cell differential count, since early discontinuation is the key to successful resolution of neutropenia. Switching from MMF to azathioprine or administration of G-CSF with or without MMF discontinuation might be options for treatment to avoid subsequent rejection.

摘要

一位 27 岁女性接受其母亲活体肾脏移植。她接受了巴利昔单抗、他克莫司、霉酚酸酯(MMF)和皮质类固醇治疗。移植前,她的全血细胞计数和白细胞分类正常。术后约 70 天(POD70),她的白细胞(WBC)计数开始下降。POD113 时,她的 WBC 计数为 2800/μL。没有病毒感染、其他全身感染或恶性肿瘤的证据。怀疑药物诱导性中性粒细胞减少症,尤其是 MMF 诱导性中性粒细胞减少症,减少了 MMF 的剂量。然而,2 周内中性粒细胞计数降至 0/μL。我们进一步减少了 MMF 的剂量并给予了粒细胞集落刺激因子(G-CSF),这仅暂时增加了中性粒细胞计数。随后停用 MMF 并改用硫唑嘌呤,中性粒细胞计数恢复而没有随后发生排斥反应。MMF 诱导的中性粒细胞减少症经常发生,不仅应通过白细胞计数监测,还应通过白细胞分类计数监测,因为早期停药是成功解决中性粒细胞减少症的关键。从 MMF 转换为硫唑嘌呤或在不停止使用 MMF 的情况下使用 G-CSF 可能是避免随后发生排斥反应的治疗选择。

相似文献

1
Mycophenolate mofetil-induced agranulocytosis in a renal transplant recipient.霉酚酸酯致肾移植受者粒细胞缺乏症。
Clin Exp Nephrol. 2010 Dec;14(6):637-40. doi: 10.1007/s10157-010-0323-y. Epub 2010 Aug 7.
2
Sirolimus: a switch option for mycophenolate mofetil-induced leukopenia in renal transplant recipients.西罗莫司:肾移植受者中霉酚酸酯所致白细胞减少症的一种替代选择。
Transplant Proc. 2013 Oct;45(8):2968-9. doi: 10.1016/j.transproceed.2013.08.040.
3
[Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report].
Hinyokika Kiyo. 2014 Jun;60(6):275-8.
4
Severe neutropenia in a renal transplant patient suggesting an interaction between mycophenolate and fenofibrate.
Curr Drug Saf. 2012 Feb;7(1):24-9. doi: 10.2174/157488612800492708.
5
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation.尸体肾移植后他克莫司(普乐可复)联合硫唑嘌呤或霉酚酸酯与环孢素(新山地明)联合霉酚酸酯的随机试验
Transplantation. 2000 Mar 15;69(5):834-41. doi: 10.1097/00007890-200003150-00028.
6
Mycophenolate mofetil in pancreas transplantation.霉酚酸酯在胰腺移植中的应用
Transplantation. 1998 Aug 15;66(3):318-23. doi: 10.1097/00007890-199808150-00007.
7
Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.霉酚酸酯预防尸体肾移植受者急性排斥反应的研究。美国肾移植霉酚酸酯研究组。
Transplantation. 1995 Aug 15;60(3):225-32. doi: 10.1097/00007890-199508000-00003.
8
Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group.他克莫司与霉酚酸酯(MMF)联合应用于尸体肾移植受者的安全性和有效性。FK506/MMF剂量范围肾移植研究组。
Transplantation. 2000 Mar 15;69(5):875-80. doi: 10.1097/00007890-200003150-00035.
9
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.肾移植中新型免疫抑制方案的临床疗效与成本效益:一项系统评价与模型研究
Health Technol Assess. 2005 May;9(21):1-179, iii-iv. doi: 10.3310/hta9210.
10
Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection.
Transplantation. 1999 Jul 15;68(1):83-6. doi: 10.1097/00007890-199907150-00016.

引用本文的文献

1
Impact of G-CSF Therapy on Leukopenia and Acute Rejection Following Kidney Transplantation.粒细胞集落刺激因子治疗对肾移植后白细胞减少和急性排斥反应的影响。
Int J Organ Transplant Med. 2021;12(2):1-8.
2
Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians.肾移植中药物诱导的血细胞减少及其给肾移植医生带来的挑战
J Transplant. 2018 Aug 1;2018:9429265. doi: 10.1155/2018/9429265. eCollection 2018.

本文引用的文献

1
Incidence, risk factors and clinical consequences of neutropenia following kidney transplantation: a retrospective study.肾移植后中性粒细胞减少症的发病率、危险因素及临床后果:一项回顾性研究。
Am J Transplant. 2009 Aug;9(8):1816-25. doi: 10.1111/j.1600-6143.2009.02699.x. Epub 2009 Jun 16.
2
Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil.缬更昔洛韦与霉酚酸酯联用导致肾移植患者白细胞减少。
Transplant Proc. 2008 Apr;40(3):752-4. doi: 10.1016/j.transproceed.2008.02.048.
3
Correlation between body mass index and leucopenia after administration of valganciclovir for cytomegalovirus infection in chinese cardiac recipients.
中国心脏移植受者巨细胞病毒感染应用缬更昔洛韦治疗后体重指数与白细胞减少的相关性
Circ J. 2007 Jun;71(6):968-72. doi: 10.1253/circj.71.968.
4
Rabbit antithymocyte globulin versus basiliximab in renal transplantation.兔抗胸腺细胞球蛋白与巴利昔单抗在肾移植中的比较
N Engl J Med. 2006 Nov 9;355(19):1967-77. doi: 10.1056/NEJMoa060068.
5
Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
Nephrol Dial Transplant. 2007 Feb;22(2):671-2. doi: 10.1093/ndt/gfl539. Epub 2006 Sep 15.
6
Mycophenolate mofetil-induced neutropenia in liver transplantation.霉酚酸酯导致肝移植术后中性粒细胞减少症。
Transplant Proc. 2005 Apr;37(3):1509-11. doi: 10.1016/j.transproceed.2005.02.038.
7
Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation.糖皮质激素会干扰肾移植中霉酚酸酯的生物利用度。
Kidney Int. 2002 Sep;62(3):1060-7. doi: 10.1046/j.1523-1755.2002.00531.x.
8
Neutrophil dysplasia caused by mycophenolate mofetil.霉酚酸酯引起的中性粒细胞发育异常。
Transplantation. 2000 Dec 15;70(11):1608-10. doi: 10.1097/00007890-200012150-00012.
9
Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.霉酚酸酯治疗的肾移植患者中霉酚酸药代动力学参数与副作用的相关性
Clin Chem. 2001 Jan;47(1):88-94.
10
The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.单剂量口服吗替麦考酚酯在不同程度肾功能患者中的药代动力学。
Clin Pharmacol Ther. 1998 May;63(5):512-8. doi: 10.1016/S0009-9236(98)90102-3.